To Treat Prostate Cancer More Evidence Needs to Wait

April 15, 2011 - PRLog -- April 13, 2011 the New York news about the new study of reasonable option for a treating the prostate cancer is needs to have evidence that closely watching the tumor for older men with low risk prostate cancer.

According to the report in the Journal of Clinical Oncology, in the study of more than 650 men who averaged 66 years old, most were able to go for 5 years without any treatment for their prostate cancer.

For more details and a preview look here:
http://www.knowthecancer.com/to-treat-prostate-cancer-more-evidence-needs-to-wait

According to Dr. H. Ballentine Carter, professor of urology and oncology at Johns Hopkins University School of Medicine in Baltimore, Maryland, "The underlying problem is that we're over-treating prostate cancer because we don't have a perfect method of identifying those people that will never be harmed by their cancer."

"In general, the broad numbers of (prostate) cancers are of the slow-growing variety that a person could live with for years," Carter, who co-authored the study.

Dr. Otis Brawley, chief medical officer of the American Cancer Society, who was not part of the study, said that, “Prostate cancer screening through PSA (prostate-specific antigen) testing has helped find cancers that never would have caused problems.” But Dr. H. Ballentine Carter said that the PSA test spend amount of $20 to $30.

In past studies about the prostate cancer treatment shown that the screening doesn’t help men live longer and not treating the cancer but it may result in huge number of death rates. Contrarily to these statements that the ease of using the test to screen men has led to growing concern that low-risk cancers are being over diagnosed, particularly in older men more likely to die of some other cause before the prostate cancer ever becomes an issue.

The U.S. Preventative Services Task Force does not recommend screening men older than 75, and says there isn't enough evidence of whether it's useful for younger men it was based on other findings.

For those men over 65 who are tested and diagnosed with a low-risk prostate cancer, "the first question is not how I'm going to treat, but if I'm going to treat or not," Carter said.

Checking PSA levels and yearly biopsies are the researchers used for active surveillance. This approach, if the tumors are progressed, the cancer patient will undergo medical treatment such as radiation or surgery. These treatments are expensive and have a lot of side effects.

The study was held on more than 650 men aging average of 66 years old, who diagnosed with very low risk of prostate cancer. This study done by 15 years, by the end of the study about 400 participants had no treatment for their cancer, and about 250 did.

Dr. Maxwell Meng, associate professor of urology at the University of California San Francisco said, "If we delay treatment, the outcomes will be the same down the line as (treating) when we get the initial diagnosis. That looks to be the case." And "Some cancers may not need immediate treatment, and it may be safe to watch if that's what (the patient) wants to do."

For more details and a preview look here:
http://www.knowthecancer.com/to-treat-prostate-cancer-mor...


# # #

Know The Cancer is a topic to gives facts causes cancers. This may elaborate different types of cancers; it gives details throughout the whole system either for men or women: http://www.knowthecancer.com